Chinese Lab Has 10 Bodies Frozen, Dozens Committed for ‘Reanimation’ in the Future


Chinese researchers are taking a new approach in cryonics in a bid to revolutionize human organ transplants. 

What is cryonics? The concept of cryonics involves preserving a human corpse  at extremely low temperatures for the purpose of future “reanimation.”

  • The concept is based on the hope that a technology allowing resurrection will be available in the future, according to Quartz.
  • There are now over 300 bodies and brains “preserved in the world’s three known commercial cryonics facilities: Alcor; the Cryonics Institute in Clinton Township, Michigan; and KrioRus near Moscow.”
  • While critics in the scientific community doubt such a probability, cryonics has remained a popular subject in science fiction.
  • In 2015, author Du Hong became the first Chinese-born subject to be placed in a cryonics suspension procedure. 
  • Hong is notably the editor of the “The Three-Body Problem,” a science fiction novel by Liu Cixin which uses elements of cryonics in its plot.

Life preservation: The Shandong Yinfeng Life Science Research Institute, which was set up in Jinan, China in 2015, is now spearheading the study on cryonics’ possible applications on medical treatments, South China Morning Post reported. As the only cryonics research facility in China, Yinfeng provides cryonic suspension and storage services for deceased humans and pets.

  • The facility aims to make use of the concept’s potential to solve current limitations on organ transplants and body part reattachments.
  • Yinfeng has 10 bodies already frozen with “dozens more who have committed” to the service.
  • Yinfeng also operates in partnership with mainland Chinese hospitals and universities to study cryobiology, which researches “the effects of low temperatures on living things.”
  • According to Yinfeng’s clinical response center director Aaron Drake, organ transplant procedures are limited by the short window of opportunity to source an organ from the deceased and implant it into a patient.
  • The focus of their research involves extending the life of an organ or body part which may expire just hours after being sourced from the deceased.
  • Yinfeng is currently researching the preservation of pancreatic cells with the University of Science and Technology of China and the preservation of ovarian cells with Qilu Hospital at Shandong University.
  • Aside from transplants, Yinfeng is also doing cryonics research to possibly help “treat heart attack, stroke and blunt trauma patients.”

Featured Image via Getty

Support our Journalism with a Contribution

Many people might not know this, but despite our large and loyal following which we are immensely grateful for, NextShark is still a small bootstrapped startup that runs on no outside funding or loans.

Everything you see today is built on the backs of warriors who have sacrificed opportunities to help give Asians all over the world a bigger voice.

However, we still face many trials and tribulations in our industry, from figuring out the most sustainable business model for independent media companies to facing the current COVID-19 pandemic decimating advertising revenues across the board.

We hope you consider making a contribution so we can continue to provide you with quality content that informs, educates and inspires the Asian community. Even a $1 contribution goes a long way. Thank you for everyone’s support. We love you all and can’t appreciate you guys enough.

NextShark is a leading source covering Asian American News and Asian News including business, culture, entertainment, politics, tech and lifestyle.

For advertising and inquiries: